Amylyx Pharmaceuticals Closes $135M Series C Financing Led By Viking Global Investors To Support Late Stage Development Of Lead Product Candidate Amx0035 For The Treatment Of Als
Amount Raised
$135 Million
Round Type
Series C
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Amylyx Pharmaceuticals, Inc. today announced the closing of an oversubscribed $135 million Series C financing, led by Viking Global Investors, to support the clinical development and potential launch plans for lead product candidate AMX0035, for the potential treatment of ALS, and further research and development in other neurodegenerative diseases.
Quick answer
Amylyx Pharmaceuticals raised $135 Million in a Series C round, dated July 20, 2021. Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- How much did Amylyx Pharmaceuticals raise?
- Amylyx Pharmaceuticals raised $135 Million in a Series C round on July 20, 2021.
- What does Amylyx Pharmaceuticals do?
- Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments.
- Where is Amylyx Pharmaceuticals based and how big is it?
- Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States. Fundz records about 384 employees.
- Who are the decision-makers at Amylyx Pharmaceuticals?
- Fundz holds 1 contact at Amylyx Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Amylyx Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $1M on September 1, 2021.
- Azora Therapeutics, Inc. (DE) raised $500K on July 12, 2021.
- Arbutus raised $81M on June 23, 2021.
- Zevra Therapeutics, Inc. raised $39M on June 22, 2021.
- Disc raised $90M (Series B) on September 2, 2021.
- Aarvik Therapeutics raised $8.3M on September 2, 2021.
Who to call at Amylyx Pharmaceuticals, and when
A new round usually means Amylyx Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amylyx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amylyx Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amylyx Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amylyx Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Amylyx Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.